
Opinion|Videos|May 12, 2025
The Biggest Challenges in Distinguishing ccRCC From Benign Renal Masses
Panelists discuss how evaluating a renal mass requires considering multiple factors, including patient expectations, comorbidities, life expectancy, tumor characteristics such as size and enhancement patterns, and predictive models to help guide decision-making.
Advertisement
Episodes in this series

Clinical Challenges in Renal Mass Evaluation
Main Discussion Topics:
- Multiple factors influence management decisions, including patient expectations, comorbidities, life expectancy, and tumor characteristics.
- Tumor assessment includes size, growth kinetics, and enhancement characteristics.
- Predictive models help assess patient longevity and tumor behavior.
Key Points for Physicians:
- Comprehensive assessment requires consideration of patient factors and tumor characteristics.
- Enhancement patterns on imaging provide valuable diagnostic information.
- Existing predictive models can help guide clinical decision-making.
Notable Insights:
Decision-making for renal masses requires a multifaceted approach that integrates patient-specific factors with tumor radiographic characteristics.
Clinical Significance:
A systematic approach that considers both patient factors and tumor characteristics leads to more appropriate management decisions for renal masses.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Prof Declan Murphy discusses PROTEUS pathologic response findings in prostate cancer
2
FDA updates in urology: August 2026
3
What POTOMAC Data Mean for Combination Therapy and Patient Selection
4
Timothy McClure, MD, on 2-year PRESERVE trial results for focal IRE
5







